News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to $11.4 billion.

It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Scotiabank raised the firm’s price target on Thermo Fisher (TMO) to $650 from $605 and keeps a Sector Perform rating on the shares. The ...

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Raymond James analyst Andrew Cooper maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $667.00.

State and local officials are seeking permission from the Wisconsin Legislature to offer additional financial incentives to ...

Another way to gauge the sentiment on Thermo Fisher Scientific is to look at the percentage of institutions that are invested ...

The American biomedical company Thermo Fisher describes a prominent product featured on its website, the RapidHIT ID system, ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The Vanguard Communications Services ETF and the Vanguard Health Care ETF outperformed the broader S&P 500 in January. Communications companies are forecast to report earnings growth of 15.2% in 2025, ...